Physician profile
Patrick Ross
NPI 1992744783
$956,463.65
in general payments reported to CMS, 2019-2025
15 companies · $172K in 2025
The $172K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144K · 2020: $48K · 2021: $135K · 2022: $174K · 2023: $139K · 2024: $144K · 2025: $172K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $323K · Travel and Lodging: $68K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Food and Beverage: $9,553 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $323,002.40 |
| Travel and Lodging | $68,137.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,895.00 |
| Food and Beverage | $9,553.13 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $949,927.18 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Siemens Medical Solutions USA, INC. | $3,847.77 | 2019-2023 | Cios Spin |
| Edwards Lifesciences Corporation | $1,273.49 | 2019 | |
| Stryker Corporation | $412.96 | 2021 | |
| Medtronic, INC. | $229.86 | 2022-2023 | Signia |
| Galvanize Therapeutics, INC | $182.69 | 2024-2025 | Aliya System |
| Ethicon INC. | $172.72 | 2019 | |
| Celgene Corporation | $138.57 | 2019 | |
| Abbott Laboratories | $109.11 | 2023 | Epic |
| Pinnacle Biologics, INC | $74.76 | 2019 | |
| Davol INC. | $24.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $19.91 | 2019 | |
| Lemaitre Vascular, INC. | $18.42 | 2019 | |
| Innocoll Pharmaceuticals Limited | $18.38 | 2021 | |
| Lilly USA, LLC | $13.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.